Christian Schetter Ph.D Overview
- Company
- Eternygen
- Primary Position
-
Chairman
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
- Med. Valuation
-
Christian Schetter Ph.D General Information
Biography
Dr. Christian Schetter served as Chief Scientific Officer & Board Member at Rentschler Biopharma. He serves as Chairman at Eternygen. He served as Managing Director at Arix Bioscience. He also served as Board Member at Twelve Bio. He served as Chief Executive Officer and Board Member at Rigontec. He serves as Board Member at Pyxis Oncology and Aura Biosciences. He serves as Chairman at STipe Therapeutics. He joined Rigontec from Neovii Biotech, previously Fresenius Biotech, where he was President and Chief Executive Officer from 2008 until 2014. During his tenure, one antibody product was brought to market and the indication for another product expanded. Dr. Schetter was instrumental in selling Fresenius Biotech to the Neopharm Group to form Neovii Biotech and positioning it as a successful standalone business. From 1998 to 2008, he was Senior Vice President, European Operations of Coley Pharmaceutical Group, a pioneer in the development of immunostimulatory oligonucleotides, and served as Managing Director of Coley. He was part of the leadership team which built Coley Pharmaceuticals from inception through multiple financing rounds, a NASDAQ IPO and, following a number of significant pharma deals, to a trade sale to Pfizer in 2007. He received his undergraduate degree and PhD from the University of Cologne followed by a postdoctoral research in oncology and virology at the Scripps Research Institute in La Jolla, California and the Max Planck Institute in Martinsried, Germany. He is a member of the Executive Board of BIO Deutschland, the German industry association for biotech companies. He also served as Board member at OMEICOS Therapeutics.
Contact Information
Address
- Karl-Liebknecht Strasse 34
- 10178 Berlin
- Germany
Christian Schetter Ph.D Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Eternygen | Company | Chairman | Berlin, Germany | Biotechnology |
Christian Schetter Ph.D Board Seats (4)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Aura Biosciences | Drug Discovery | Publicly Held | Formerly VC-backed | Cambridge, MA | |
Eternygen | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Berlin, Germany | |
Pyxis | Other Devices and Supplies | Acquired/Merged | Corporate Backed or Acquired | San Diego, CA | |
STipe Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Copenhagen, Denmark |
Christian Schetter Ph.D Lead Partner on Deals (3)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Aura Biosciences | 22-Mar-2021 | Later Stage VC (Series E) | Completed | Drug Discovery | Cambridge, MA | |
Twelve bio | 09-Mar-2021 | Completed | Other Healthcare Technology Systems | Copenhagen, Denmark | ||
Pyxis Oncology | 05-Mar-2021 | Completed | Drug Discovery | Boston, MA |
Christian Schetter Ph.D Network (117)
Board Members (79)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Christiane Bardroff | Rentschler Biopharma | Rentschler Biopharma | Laupheim, Germany | |
Shaan Gandhi Ph.D | Pyxis Oncology | Self | Boston, MA | |
OMEICOS Therapeutics | High-Tech Gründerfonds | Berlin, Germany | ||
STipe Therapeutics | Self | Copenhagen, Denmark | ||
Pyxis | Self | San Diego, CA |
Portfolio Executives (38)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Conor Kilroy | Aura Biosciences | General Counsel, Legal & Secretary, Administration | 22-Mar-2021 | Cambridge, MA |
Cadmus Rich MD | Aura Biosciences | Chief Medical Officer | 22-Mar-2021 | Cambridge, MA |
Aura Biosciences | Senior Vice President, Development | 22-Mar-2021 | Cambridge, MA | |
Aura Biosciences | Chief Financial Officer | 22-Mar-2021 | Cambridge, MA | |
Aura Biosciences | Director, Research | 22-Mar-2021 | Cambridge, MA |
Christian Schetter Ph.D FAQs
-
Who is Christian Schetter Ph.D?
Dr. Christian Schetter served as Chief Scientific Officer & Board Member at Rentschler Biopharma.
-
How much does Christian Schetter Ph.D typically invest?
Christian Schetter Ph.D's median deal size is
. -
What is Christian Schetter Ph.D’s main position?
Christian Schetter Ph.D’s primary position is Chairman.
-
How many active board seats does Christian Schetter Ph.D hold?
Christian Schetter Ph.D holds 4 board seats including Aura Biosciences, Eternygen, Pyxis, and STipe Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »